Hyaluronidase: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Hyaluronidase. Educational only — not medical advice.

Labeled uses

HYLENEX recombinant is an endoglycosidase indicated as an adjuvant in subcutaneous fluid administration for achieving hydration (1.1 ) to increase the dispersion and absorption of other injected drugs (1.2 ) in subcutaneous urography for improving resorption of radiopaque agents (1.3 )

Source: FDA labeling via NIH DailyMed (set 3023cc56…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.